Evidence map›Paper›PMID 38414658›Full record

ArticleJournal of biomedical optics2024

First in human measurements of abscess cavity optical properties and methylene blue uptake prior to photodynamic therapy by

Md Nafiz Hannan, Ashwani K Sharma, Timothy M Baran

Abstract readClinical Trial, Phase I
In one paragraph

Article in Journal of biomedical optics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Md Nafiz HannanUniversity of Rochester, Department of Physics and Astronomy, Rochester, New York, United States.
Ashwani K SharmaUniversity of Rochester Medical Center, Department of Imaging Sciences, Rochester, New York, United States.ORCID 0000-0001-7543-7598
Timothy M BaranUniversity of Rochester Medical Center, Department of Imaging Sciences, Rochester, New York, United States.ORCID 0000-0002-4476-5609

Funding

Optical property measurement in human abscess cavities for photodynamic therapy treatment planningR01EB029921 · NIBIB · UNIVERSITY OF ROCHESTER · PI BARAN, TIMOTHY M · 2020 to 2023
$827k
NIBIB NIH HHS R01 EB029921
6 · The paper itself

Abstract

Significance: Efficacious photodynamic therapy (PDT) of abscess cavities requires personalized treatment planning. This relies on knowledge of abscess wall optical properties, which we report for the first time in human subjects. Aim: The objective was to extract optical properties and photosensitizer concentration from spatially resolved diffuse reflectance measurements of abscess cavities prior to methylene blue (MB) PDT, as part of a phase 1 clinical trial. Approach: Diffuse reflectance spectra were collected at the abscess wall of 13 human subjects using a custom fiber-optic probe and optical spectroscopy system, before and after MB administration. A Monte Carlo lookup table was used to extract optical properties. Results: Pre-MB abscess wall absorption coefficients at 665 nm were Conclusions: We observed substantial inter-subject variation in both native wall optical properties and MB uptake. This underscores the importance of making these measurements for patient-specific treatment planning.

Indexed as

Methylene BluePhotochemotherapyAbscessHumansPhotosensitizing AgentsSpectrum AnalysisMethylene BluePhotosensitizing Agentsdiffuse reflectance spectroscopyhemodynamicsintra-abdominal abscessmethylene blueoptical propertiesphotodynamic therapy

Identifiers

PMID38414658
PMCPMC10898190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.